IL-12 promotes the differentiation of naïve CD8+ T cells to the effector phenotype and acts as a CD8+ T-anti-apoptotic factor that can directly destroy microorganisms and cancer cells through the release of perforin and proteolytic enzymes [362,363]. The gene discussed is PRF1; the disease is cancer.